RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion

Nature Neuroscience

Volumn 9, Issue 6, 2006, Pages 832-842

  Ding, Jun ^a   Guzman, Jaime N ^a   Tkatch, Tatiana ^a   Chen, Songhai ^b   Goldberg, Joshua A ^c   Ebert, Philip J ^b   Levitt, Pat ^b,d   Wilson, Charles J ^c   Hamm, Heidi E ^b   Surmeier, D James ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTORECEPTOR; GUANOSINE TRIPHOSPHATASE;

ACETYLCHOLINE RELEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE EXACERBATION; INTERNEURON; MOUSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

ACETYLCHOLINE; ACTION POTENTIALS; ANIMALS; AUTORECEPTORS; CALCIUM CHANNELS; CELL COMMUNICATION; CORPUS STRIATUM; DOPAMINE; DOWN-REGULATION; INTERNEURONS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCARINIC AGONISTS; OXOTREMORINE; PARKINSON DISEASE; RATS; RECEPTOR, MUSCARINIC M4; RECEPTORS, DOPAMINE D2; RGS PROTEINS; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; UP-REGULATION;

EID: 33745712929     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn1700     Document Type: Article

References (49)

1. Albin, R.L., Young, A.B. & Penney, J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366-375 (1989).
2. Freund, T.F. et al. Efferent synaptic connections of grafted dopaminergic neurons reinnervating the host neostriatum: a tyrosine hydroxylase immunocytochemical study. J. Neurosci. 5, 603-616 (1985).
3. Nastuk, M.A. & Graybiel, A.M. Patterns of muscarinic cholinergic binding in the striatum and their relation to dopamine islands and striosomes. J. Comp. Neurol. 237, 176-194 (1985).
4. Barbeau, A. The pathogenesis of Parkinson's disease: a new hypothesis. Can. Med. Assoc. J. 87, 802-807 (1962).
5. Wooten, G. Parkinsonism. in Neurobiology of Disease (eds. Pearlman, A.L. & Collins, R.C.) Ch. 23, 454-468 (Oxford Univ. Press, New York, 1990).
6. MacKenzie, R.G., Stachowiak, M.K.& Zigmond, M.J. Dopaminergic inhibition of striatal acetylcholine release after 6-hydroxydopamine. Eur. J. Pharmacol. 168, 43-52 (1989).
7. DeBoer, P., Heeringa, M.J. & Abercrombie, E.D. Spontaneous release of acetylcholine in striatum is preferentially regulated by inhibitory dopamine D2 receptors. Eur. J. Pharmacol. 317, 257-262 (1996).
8. 2+ currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-C-insensitive pathway. J. Neurophysiol. 77, 1003-1015 (1997).
9. + channels reduces autonomous activity in striatal cholinergic interneurons. J. Neurosci. 24, 10289-10301 (2004).
10. Wichmann, T., Wictorin, K., Bjorklund, A. & Starke, K. Release of acetylcholine and its dopaminergic control in slices from striatal grafts in the ibotenic acid-lesioned rat striatum. Naunyn Schmiedebergs Arch. Pharmacol. 338, 623-631 (1988).
11. Aosaki, T., Graybiel, A.M. & Kimura, M. Effect of the nigrostriatal dopamine system on acquired neural responses in the striatum of behaving monkeys. Science 265, 412-415 (1994).
12. Raz, A., Feingold, A., Zelanskaya, V., Vaadia, E. & Bergman, H. Neuronal synchronization of tonically active neurons in the striatum of normal and parkinsonian primates. J. Neurophysiol. 76, 2083-2088 (1996).
13. Calabresi, P. et al. Muscarinic IPSPs in rat striatal cholinergic interneurones. J. Physiol. (Lond.) 510, 421-427 (1998).
14. 2+ currents in rat neostriatal cholinergic interneurons through a fast, membrane-delimited, G-protein pathway. J. Neurosci. 16, 2592-2604 (1996).
15. Zhang, W. et al. Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice. J. Neurosci. 22, 1709-1717 (2002).
16. De Vries, L., Zheng, B., Fischer, T., Elenko, E. & Farquhar, M.G. The regulator of G protein signaling family. Annu. Rev. Pharmacol. Toxicol. 40, 235-271 (2000).
17. Ni, Y.G. et al. Region-specific regulation of RGS4 (regulator of G-protein-signaling protein type 4) in brain by stress and glucocorticoids: in vivo and in vitro studies. J. Neurosci. 19, 3674-3680 (1999).
18. Geurts, M., Hermans, E. & Maloteaux, J.M. Opposite modulation of regulators of G protein signalling-2 RGS2 and RGS4 expression by dopamine receptors in the rat striatum. Neurosci. Lett. 333, 146-150 (2002).
19. Geurts, M., Maloteaux, J.M. & Hermans, E. Altered expression of regulators of G-protein signaling (RGS) mRNAs in the striatum of rats undergoing dopamine depletion. Biochem. Pharmacol. 66, 1163-1170 (2003).
20. Rahman, Z. et al. RGS9 modulates dopamine signaling in the basal ganglia. Neuron 38, 941-952 (2003).
21. Hu, X.T., Wachtel, S.R., Galloway, M.P. & White, F.J. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation. J. Neurosci. 10, 2318-2329 (1990).
22. Mileson, B.E., Lewis, M.H. & Mailman, R.B. Dopamine receptor 'supersensitivity' occurring without receptor up-regulation. Brain Res. 561, 1-10 (1991).
23. Kawaguchi, Y., Wilson, C.J., Augood, S.J. & Emson, P.C. Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci. 18, 527-535 (1995).
24. Cooper, J.R., Bloom, F.E. & Roth, R.H. Biochemical Basis of Neuropharmacology 7th edn. (Oxford University Press, New York, 1996).
25. Esaki, T. et al. Developmental disruption of serotonin transporter function impairs cerebral responses to whisker stimulation in mice, Proc. Natl. Acad. Sci. USA 102, 5582-5587 (2005).
26. Joyce, J.N. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment. Exp. Neurol. 113, 277-290 (1991).
27. Ueda, H. et al. Supersensitization of neurochemical responses by L-DOPA and dopamine receptor agonists in the striatum of experimental Parkinson's disease model rats. Biomed. Pharmacother. 49, 169-177 (1995).
28. 2+ channel inhibition in rat striatal cholinergic interneurons. Proc. Natl. Acad. Sci. USA 101, 16339-16344 (2004).
29. Conklin, B.R. & Bourne, H.R. Structural elements of G alpha subunits that interact with G beta gamma, receptors, and effectors. Cell 73, 631-641 (1993).
30. Martin, E.L., Rens-Domiano, S., Schatz, P.J. & Hamm, H.E. Potent peptide analogues of a G protein receptor-binding region obtained with a combinatorial library. J. Biol. Chem. 271, 361-366 (1996).
31. Hamm, H.E. et al. Site of G protein binding to rhodopsin mapped with synthetic peptides from the alpha subunit. Science 241, 832-835 (1988).
32. Rasenick, M.M., Watanabe, M., Lazarevic, M.B., Hatta, S. & Hamm, H.E. Synthetic peptides as probes for G protein function. Carboxyl-terminal G alpha s peptides mimic Gs and evoke high affinity agonist binding to beta-adrenergic receptors. J. Biol. Chem. 269, 21519-21525 (1994).
33. Zeng, W. et al. The N-terminal domain of RGS4 confers receptor-selective inhibition of G protein signaling. J. Biol. Chem. 273, 34687-34690 (1998).
34. Golard, A. & Siegelbaum, S.A. Kinetic basis for the voltage-dependent inhibition of N-type calcium current by somatostatin and norepinephrine in chick sympathetic neurons. J. Neurosci. 13, 3884-3894 (1993).
35. Zamponi, G.W. & Snutch, T.P. Decay of prepulse facilitation of N type calcium channels during G protein inhibition is consistent with binding of a single Gbeta subunit. Proc. Natl. Acad. Sci. USA 95, 4035-4039 (1998).
36. Bennett, B.D., Callaway, J.C. & Wilson, C.J. Intrinsic membrane properties underlying spontaneous tonic firing in neostriatal cholinergic interneurons. J. Neurosci. 20, 8493-8503 (2000).
37. Pepperl, D.J., Shah-Basu, S., VanLeeuwen, D., Granneman, J.G. & MacKenzie, R.G. Regulation of RGS mRNAs by cAMP in PC12 cells. Biochem. Biophys. Res. Commun. 243, 52-55 (1998).
38. Inanobe, A. et al. Interaction between the RGS domain of RGS4 with G protein alpha subunits mediates the voltage-dependent relaxation of the G protein-gated potassium channel. J. Physiol. (Lond.) 535, 133-143 (2001).
39. Siderovski, D.P. & Willard, F.S. The GAPs, GEFs, and GDIs of heterotrimeric G-protein alpha subunits. Int. J. Biol. Sci. 1, 51-66 (2005).
40. Bernstein, L.S. et al. RGS2 binds directly and selectively to the M1 muscarinic acetylcholine receptor third intracellular loop to modulate Gq/11alpha signaling. J. Biol. Chem. 279, 21248-21256 (2004).
41. Xu, X. et al. RGS proteins determine signaling specificity of Gq-coupled receptors. J. Biol. Chem. 274, 3549-3556 (1999).
42. Goldberg, J.A. & Wilson, C.J. Control of spontaneous firing patterns by the selective coupling of calcium currents to calcium activated potassium currents in striatal cholinergic interneurons. J. Neurosci. 25, 10230-10238 (2005).
43. 2+ channels: a functional patchwork. Trends Neurosci. 26, 683-687 (2003).
44. Dolezal, V. & Wecker, L. Muscarinic receptor blockade increases basal acetylcholine release from striatal slices. J. Pharmacol. Exp. Ther. 252, 739-743 (1990).
45. Graybiel, A.M., Aosaki, T., Flaherty, A.W. & Kimura, M. The basal ganglia and adaptive motor control. Science 265, 1826-1831 (1994).
46. LaHoste, G.J., Yu, J. & Marshall, J.F. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. Proc. Natl. Acad. Sci. USA 90, 7451-7455 (1993).
47. + current amplitude are linearly related in basal ganglia and basal forebrain neurons. J. Neurosci. 20, 579-588 (2000).
48. Skiba, N.P., Bae, H. & Hamm, H.E. Mapping of effector binding sites of transducin alpha-subunit using G alpha t/G alpha i1 chimeras. J. Biol. Chem. 271, 413-424 (1996).
49. Berman, D.M., Kozasa, T. & Gilman, A.G. The GTPase-activating protein RGS4 stabilizes the transition state for nucleotide hydrolysis. J. Biol. Chem. 271, 27209-27212 (1996).